This site is intended only for healthcare professionals resident in the United Kingdom
IBRANCE is indicated for the treatment of HR+/HER2-, locally advanced or mBC in combination with an AI or with fulvestrant in women who have received prior ET. In pre-and peri-menopausal women, the ET should be combined with a LHRH agonist.
Dr Erling Donnelly
Pfizer's commitment to the oncology community through the COVID-19 pandemic
Dr Erling Donnelly, Head of Oncology, Pfizer UK on Pfizer's commitment to the oncology community through the COVID-19 pandemic.